Andrew Levin, PhD, MD

Partner and Managing Director

Andrew Levin is a Partner with the Investment team at RA Capital Management. Andrew’s primary responsibilities are to build and invest in early-stage private companies across biotech, healthcare technologies, and services. Prior to RA, Andrew served as a Vice President at H.I.G. BioVentures and Director of Pharmaceutical Sciences at the Clinton Health Access Initiative. Andrew holds a Bachelor of Science in Engineering in Mechanical Engineering from Princeton University, a PhD in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD from Harvard Medical School.